gastroesophageal cancer
Culmination Bio, Cofactor Genomics Team up on Study to Advance Immunotherapy Response Test
Culmination will give Cofactor access to over 4.5 million biological samples to advance the firm's assay to predict immunotherapy response in 11 cancer types.
Personalis, Duke University, Olink Collaborate on Immunotherapy Markers in Gastric Cancer
They plan to study the genomic, transcriptomic, and proteomic responses of gastroesophageal tumors following treatment with Merck's Keytruda.
Gastric Cancer Cases Frequently Harbor Genetic Risk Variants, Suggesting Germline Testing
Using panel sequence data for more than 500 esophagogastric cancer cases, researchers found pathogenic or likely pathogenic variants in almost 20 percent of those with gastric cancers.
Cancer, Pathology Organizations Developing Clinical Guidelines for MMR, MSI Testing
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors
Palmetto has expanded the local coverage determination for the Guardant360 liquid biopsy assay to be used with the majority of advanced solid tumors.